Dr. Callum is a Professor in the Department of Pathology and Molecular Medicine. Her funded research project is titled: Prospective, multicentre, randomized, parallel-control, superiority study comparing administration of clotting factor concentrates with a standard massive hemorrhage protocol in severely bleeding trauma patients.

Dr. Lois Mulligan

Dr. Mulligan is a Professor in the Department of Pathology and Molecular Medicine and a Principal Investigator at Queen’s Cancer Research Institute. Her funded research project is titled: Investigating the Regulation of RET Receptor-Mediated Perineural Invasion and Metastasis.

On the recommendation of Dean Jane Philpott, Mark Green, Provost and Vice-Principal (Academic) at Queen’s University, has appointed Dr. David M. Berman as Head, Department of Pathology and Molecular Medicine. His appointment is effective July 1, 2021 for a five-year term.

Six research projects at Queen’s have received funding from the New Frontiers in Research Fund’s (NFRF) 2020 Exploration competition, a program that encourages scholars to take risks, and that fosters discoveries and innovations that could have significant impacts on our world.

From: https://healthsci.queensu.ca/stories/news-announcements/dr-harriet-feil…

The Faculty of Health Sciences is pleased to announce the appointment of Dr. Harriet Feilotter as Director of the Ontario Molecular Pathology Research Network (OMPRN).

KATHLEEN BURNS, MD, PhD
Chair, Department of Pathology, Dana-Farber Cancer Institute,
Professor of Pathology Harvard Medical School
“Building and wrecking genomes”

Tuesday, 25 May 2021, 4:00 pm – Via Zoom